![]() |
|
|
C Stevens, M Lipman, S Fabry, M Moscovitch-Lopatin, W Almawi, S Keresztes, MA Peppercorn and TB Strom
Department of Medicine, Beth Israel Hospital, Boston, Massachusetts.
The antiinflammatory agent sulfasalazine (SS) is prescribed to treat Crohn's disease, ulcerative colitis and rheumatoid arthritis. Activated T cells are present within diseased mucosal and synovial sites. We tested whether SS or its metabolites 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP) inhibited the T-cell activation products interleukin 2 (IL-2) and interleukin 2 receptor alpha-chain (IL-2R alpha). Experiments were performed in phytohemaglutinin- and phorbol ester- stimulated peripheral blood mononuclear cells. Radioactive thymidine and leucine incorporation assayed DNA and protein synthesis, respectively. Enzyme-linked immunosorbent assay and Northern blot analysis measured IL-2 and IL-2R alpha. Lactate dehydrogenase release determined cell viability, and intracellular free calcium was measured by an indole fluorescent indicator. SS and 5-ASA, but not SP, inhibited T-cell proliferation and protein synthesis in phytohemaglutinin- and phorbol ester-stimulated peripheral blood monomuclear cells. 5-ASA (625 microM) markedly reduced culture supernatant IL-2 protein levels by 92% and steady-state IL-2 messenger RNA levels 4.4-fold at 24 and 18 hr, respectively. The supplementation of IL-2 restored T-cell proliferation only in 5-ASA-treated cultures. SS, 5-ASA and SP did not alter intracellular calcium accumulation after mitogenic stimulation. SS and 5-ASA (625 microM) caused 71% and 37% cytotoxicity, respectively, in 72- hr cultures. 5-ASA inhibits T-cell proliferation in part by blocking IL- 2 messenger RNA accumulation and protein production downstream of the rise in cytosolic calcium. Inhibition of IL-2 production is an additional mechanism of action for 5-ASA.
This article has been cited by other articles:
![]() |
J. F. Valentine Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1044 - G1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Frieri, R Giacomelli, M Pimpo, G Palumbo, A Passacantando, G Pantaleoni, and R Caprilli Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis Gut, September 1, 2000; 47(3): 410 - 414. [Abstract] [Full Text] [PDF] |
||||